These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 28739717)
1. Potential Implication of Paxillin in Cancer Establishment Within the Bone Environment. Sobkowicz AD; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2017 Aug; 37(8):4255-4268. PubMed ID: 28739717 [TBL] [Abstract][Full Text] [Related]
2. Metastasis to Bone in Human Cancer Is Associated with Loss of Occludin Expression. Martin TA; Jordan N; Davies EL; Jiang WG Anticancer Res; 2016 Mar; 36(3):1287-93. PubMed ID: 26977027 [TBL] [Abstract][Full Text] [Related]
3. Growth and differentiation factor-9 promotes adhesive and motile capacity of prostate cancer cells by up-regulating FAK and Paxillin via Smad dependent pathway. Bokobza SM; Ye L; Kynaston HG; Jiang WG Oncol Rep; 2010 Dec; 24(6):1653-9. PubMed ID: 21042764 [TBL] [Abstract][Full Text] [Related]
4. The HGF/SF-induced phosphorylation of paxillin, matrix adhesion, and invasion of prostate cancer cells were suppressed by NK4, an HGF/SF variant. Parr C; Davies G; Nakamura T; Matsumoto K; Mason MD; Jiang WG Biochem Biophys Res Commun; 2001 Aug; 285(5):1330-7. PubMed ID: 11478803 [TBL] [Abstract][Full Text] [Related]
5. Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists. Ye L; Lewis-Russell JM; Kynaston H; Jiang WG J Urol; 2007 Sep; 178(3 Pt 1):1086-91. PubMed ID: 17644136 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase-C gamma-1 (PLCgamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Davies G; Martin TA; Ye L; Lewis-Russell JM; Mason MD; Jiang WG Urol Oncol; 2008; 26(4):386-91. PubMed ID: 18367108 [TBL] [Abstract][Full Text] [Related]
7. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. Owen S; Sanders AJ; Mason MD; Jiang WG Int J Oncol; 2016 Mar; 48(3):919-28. PubMed ID: 26781475 [TBL] [Abstract][Full Text] [Related]
8. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer. Davies G; Ablin RJ; Mason MD; Jiang WG J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366 [TBL] [Abstract][Full Text] [Related]
9. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation. Sanders AJ; Parr C; Martin TA; Lane J; Mason MD; Jiang WG J Cell Physiol; 2008 Sep; 216(3):780-9. PubMed ID: 18449907 [TBL] [Abstract][Full Text] [Related]
10. Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells. Davies G; Watkins G; Mason MD; Jiang WG Prostate; 2004 Sep; 60(4):317-24. PubMed ID: 15264243 [TBL] [Abstract][Full Text] [Related]
11. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells. Kang H; Mansel RE; Jiang WG Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737 [TBL] [Abstract][Full Text] [Related]
12. ALCAM, activated leukocyte cell adhesion molecule, influences the aggressive nature of breast cancer cells, a potential connection to bone metastasis. Davies S; Jiang WG Anticancer Res; 2010 Apr; 30(4):1163-8. PubMed ID: 20530423 [TBL] [Abstract][Full Text] [Related]
13. Targeting of Receptor Activator of Nuclear Kappa B (RANK) in PC-3 Cells Increases Cell Proliferation and Matrix Adhesion In Vitro. Owen S; Sanders AJ; Mason MD; Jiang WG Anticancer Res; 2016 Mar; 36(3):1127-34. PubMed ID: 26977008 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells. Parr C; Jiang WG Int J Cancer; 2006 Sep; 119(5):1176-83. PubMed ID: 16557597 [TBL] [Abstract][Full Text] [Related]
15. Cellular interactions in the tropism of prostate cancer to bone. Sikes RA; Nicholson BE; Koeneman KS; Edlund NM; Bissonette EA; Bradley MJ; Thalmann GN; Cecchini MG; Pienta KJ; Chung LW Int J Cancer; 2004 Jul; 110(4):497-503. PubMed ID: 15122581 [TBL] [Abstract][Full Text] [Related]
16. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
17. Combined effects of furanodiene and doxorubicin on the migration and invasion of MDA-MB-231 breast cancer cells in vitro. Zhong ZF; Tan W; Tian K; Yu H; Qiang WA; Wang YT Oncol Rep; 2017 Apr; 37(4):2016-2024. PubMed ID: 28184941 [TBL] [Abstract][Full Text] [Related]
18. Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling. Sallam AA; Mohyeldin MM; Foudah AI; Akl MR; Nazzal S; Meyer SA; Liu YY; El Sayed KA Org Biomol Chem; 2014 Jul; 12(28):5295-303. PubMed ID: 24927150 [TBL] [Abstract][Full Text] [Related]
19. New Roles of Osteocytes in Proliferation, Migration and Invasion of Breast and Prostate Cancer Cells. Cui YX; Evans BA; Jiang WG Anticancer Res; 2016 Mar; 36(3):1193-201. PubMed ID: 26977015 [TBL] [Abstract][Full Text] [Related]
20. Impact of E6-associated protein on the proliferation and invasion of prostate cancer cells in bone metastasis. Zhang L; Hu X; Chen J; Fu G Int J Clin Exp Pathol; 2015; 8(6):6571-5. PubMed ID: 26261538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]